Discrepancies of assessments in a RECIST 1.1 phase II clinical trial – association between adjudication rate and variability in images and tumors selection-Reference-Cited by-同舟云学术

Discrepancies of assessments in a RECIST 1.1 phase II clinical trial – association between adjudication rate and variability in images and tumors selection

Published:2018-12 Issue:1 Volume:18 Page:
ISSN:1470-7330
Container-title:Cancer Imaging
language:en
Short-container-title:Cancer Imaging

Author:

Beaumont Hubert^ORCID,Evans Tracey L.,Klifa Catherine,Guermazi Ali,Hong Sae Rom,Chadjaa Mustapha,Monostori Zsuzsanna

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Radiological and Ultrasound Technology

Link

http://link.springer.com/content/pdf/10.1186/s40644-018-0186-0.pdf

Reference28 articles.

1. Food US, Document DAFDAB. Oncology drug advisory committee meeting BLA STN 125085/91, vol. 018. Washington, DC: Avastin® (bevacizumab). US Food Drug Adm; 2007.

2. Tang P A, Pond GR, Chen EX. influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trials. Ann Oncol 2010;21:19–26.

3. Zhao B, James LP, Moskowitz CS, Guo P, Ginsberg MS, Lefkowitz RA, et al. Evaluating Variability in Tumor Measurements from Same-day Repeat CT Scans of Patients with Non–Small Cell Lung Cancer 1. Radiology [Internet]. 2009 [cited 2014 Jan 15];252:263–272. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2797680&tool=pmcentrez&rendertype=abstract

4. Yoon SH, Kim KW, Goo JM, Kim D-W, Hahn S. Observer variability in RECIST-based tumour burden measurements: a meta-analysis. Eur J Cancer [Internet]. 2016;53:5–15. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0959804915009284

5. Clarke LP, Sriram RD, Schilling LB. Imaging as a biomarker: standards for change measurements in therapy workshop summary. Acad Radiol [Internet]. 2008;15:501–30 Available from: http://www.ncbi.nlm.nih.gov/pubmed/18389935 .

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RECIST 1.1 assessments variability: a systematic pictorial review of blinded double reads;Insights into Imaging;2024-08-07

2. Three scans are better than two for follow-up: An automatic method for finding missed and misidentified lesions in cross-sectional follow-up of oncology patients;European Journal of Radiology;2024-07

3. Can blood-based markers predict RECIST progression in non-small cell lung cancer treated with immunotherapy?;Journal of Cancer Research and Clinical Oncology;2024-06-26

4. Reproducing RECIST lesion selection via machine learning: Insights into intra and inter-radiologist variation;European Journal of Radiology Open;2024-06

5. Improvement of assessment in surrogate endpoint and safety outcome of single-arm trials for anticancer drugs;Expert Review of Clinical Pharmacology;2024-04-21